Azathioprine for pemphigus and pemphigoid—a 4 year follow‐up

British Journal of Dermatology

Volumn 91, Issue 1, 1974, Pages 103-109

  BURTON, J L ^a   GREAVES, M W ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

CANCER; CANCER INCIDENCE; DRUG THERAPY; PEMPHIGOID; PEMPHIGUS VULGARIS; THERAPY;

ADULT; AGED; ANEMIA; AZATHIOPRINE; BONE NEOPLASMS; DRUG EVALUATION; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMAN; LEUKOPENIA; MALE; MIDDLE AGE; NEOPLASM METASTASIS; PEMPHIGUS; PREDNISONE; PROSPECTIVE STUDIES; SKIN DISEASES;

EID: 0016196848     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1974.tb06725.x     Document Type: Article

References (27)

1. Chronic allogeneic disease. II. Development of lymphomas
2. 'In vitro’ evaluation of immunosuppressive drugs
3. The concept of immunological surveillance
4. Azathioprine in pemphigus vulgaris
5. Pemphigus vulgarisa skin manifestation of epidermoid carcinoma
6. Azathioprine therapy of ‘autoimmune’ diseases
7. Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis
8. Possible usefulness of azathioprine (Imuran) in severe rheumatoid arthritis
9. Azathioprine in treatment of bullous pemphigoid
10. Risk of cancer in renal transplant recipients
11. Immunosuppressants in treatment of pemphigus
12. Long‐term immunosuppressive therapy of ulcerative colitis
13. Pemphigus vulgaris
14. Oncogenicity of immunosuppressive drugs
15. Cytotoxic drugs in treatment of non‐malignant diseases
16. Anti‐inflammatory activity of 6‐mercaptopurine
17. Pemphigoid and malignancy
18. Pemphigus treatment with azathioprine
19. Pemphigus and malignancy
20. Senear‐Usher syndrome and internal malignancy
21. A case of bullous pemphigoid and figurate erythema in association with metastatic spread of carcinoma
22. ‘De novo’ brain tumours in renal transplant recipients
23. Immunoregulation, oncogenic viruses and malignant lymphomas
24. Immunosuppressive therapy
25. Skin cancer and immunosuppression
26. Immunosuppressive therapy for pemphigus vulgaris